Thus, the enhanced levels in patients with established CVD may reflect a beneficial response, correlating with the severity of the disease, to limit the extent of immune activation [6, 10], PTX3 serum levels are inversely correlated with several features of the metabolic syndrome and obesity [11, 12]. This evidence concerns the gene PTX3 and obesity due to melanocortin 4 receptor deficiency.